CD19 and tuberculosis: This was demonstrated by Ashenafi et al. in testing this assay among adults from Ethiopia; using flow cytometry, they demonstrated a greater proportion of plasmablasts (CD3− CD19+ CD20− CD27high CD38high) circulating among participants with active TB than among asymptomatic participants.